GIM
Granahan Investment Management’s Nektar Therapeutics NKTR Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q1 | – | Sell |
-156,517
| Closed | -$9.35M | – | 216 |
|
2017
Q4 | $9.35M | Sell |
156,517
-327,283
| -68% | -$19.5M | 0.74% | 43 |
|
2017
Q3 | $11.6M | Buy |
483,800
+24,599
| +5% | +$590K | 0.97% | 28 |
|
2017
Q2 | $8.98M | Sell |
459,201
-103,272
| -18% | -$2.02M | 0.83% | 35 |
|
2017
Q1 | $13.2M | Sell |
562,473
-1,253,832
| -69% | -$29.4M | 1.32% | 17 |
|
2016
Q4 | $22.3M | Sell |
1,816,305
-176,820
| -9% | -$2.17M | 0.77% | 41 |
|
2016
Q3 | $34.2M | Buy |
1,993,125
+12,790
| +0.6% | +$220K | 1.12% | 17 |
|
2016
Q2 | $28.2M | Sell |
1,980,335
-71,500
| -3% | -$1.02M | 1.03% | 23 |
|
2016
Q1 | $28.2M | Sell |
2,051,835
-30,320
| -1% | -$417K | 1.03% | 26 |
|
2015
Q4 | $35.1M | Sell |
2,082,155
-237,520
| -10% | -$4M | 1.21% | 12 |
|
2015
Q3 | $25.4M | Buy |
2,319,675
+106,900
| +5% | +$1.17M | 0.79% | 38 |
|
2015
Q2 | $27.7M | Sell |
2,212,775
-4,170
| -0.2% | -$52.2K | 0.78% | 41 |
|
2015
Q1 | $24.4M | Sell |
2,216,945
-1,293,045
| -37% | -$14.2M | 0.7% | 51 |
|
2014
Q4 | $54.4M | Buy |
3,509,990
+67,010
| +2% | +$1.04M | 1.59% | 4 |
|
2014
Q3 | $41.6M | Sell |
3,442,980
-231,346
| -6% | -$2.79M | 1.28% | 12 |
|
2014
Q2 | $47.1M | Sell |
3,674,326
-19,630
| -0.5% | -$252K | 1.37% | 10 |
|
2014
Q1 | $44.8M | Buy |
3,693,956
+466,050
| +14% | +$5.65M | 1.21% | 11 |
|
2013
Q4 | $36.6M | Buy |
3,227,906
+513,076
| +19% | +$5.82M | 0.94% | 27 |
|
2013
Q3 | $28.4M | Sell |
2,714,830
-171,370
| -6% | -$1.79M | 0.75% | 46 |
|
2013
Q2 | $33.3M | Buy |
+2,886,200
| New | +$33.3M | 0.96% | 25 |
|